FIELD: medicine.
SUBSTANCE: blood serum is examined for the concentration of alpha-2, beta and gamma-globulins, and if the concentration of alpha-2-globulins is increased to 7.6-8.2 g/l, of beta-globulins - to 10.7-11.3 g/l, and of gamma-globulins - to 18.8-19.4 g/l, low inflammatory process activity is stated, while increasing alpha-2-globulins to 10.3-12.3 g/l, beta-globulins - to 11.6-12.1 g/l, and gamma-globulins - to 20.4-31.6 g/l shows high inflammatory process activity.
EFFECT: method allows high accuracy assessment inflammatory process activity by evaluating the concentration of a complex of complementary blood serum markers reliably characterising sarcoidosis activity.
2 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR EVALUATING INFLAMMATORY PROCESS ACTIVITY AT PSORIASIS | 2005 |
|
RU2290645C1 |
METHOD FOR EVALUATING ANTIOXIDATION PROTECTION STATE IN LUNG DISEASE PATIENTS (SARCOIDOSIS, FIBROSING ALVEOLITIS, LARVAL PARAGONIMIASIS) | 1998 |
|
RU2152620C1 |
METHOD FOR PREDICTING THE CHANCE FOR OSTEOMYELITIS CHRONIZATION IN CHILDREN | 2006 |
|
RU2304784C1 |
METHOD FOR ESTIMATING INFLAMMATORY PROCESS ACTIVITY IN PEMPHIGUS CASES | 2006 |
|
RU2316003C1 |
METHOD FOR ESTIMATING PSORIATIC ERYTHRODERMIA TREATMENT EFFECTIVENESS | 2005 |
|
RU2297004C1 |
METHOD FOR PREDICTION OF GLUCOCORTICOSTEROID CLINICAL EFFECTIVENESS | 2008 |
|
RU2382364C1 |
METHOD FOR ESTIMATING PEMPHIGUS CLINICAL COURSE SEVERITY DEGREE | 2006 |
|
RU2316006C1 |
METHOD FOR ESTIMATING PEMPHIGUS TREATMENT EFFECTIVENESS | 2006 |
|
RU2316005C1 |
METHOD OF PROBABILITY PREDICTION OF CHILDREN CHRONIC HAEMATOGENOUS OSTEOMYELITIS DEVELOPMENT | 2007 |
|
RU2341798C1 |
METHOD FOR PREDICTING THE ACTIVITY OF INFLAMMATORY PROCESS AT PULMONARY SARCOIDOSIS | 2005 |
|
RU2296330C2 |
Authors
Dates
2011-07-10—Published
2010-02-11—Filed